Nolph K D, Cutler S J, Steinberg S M, Novak J W, Hirschman G H
ASAIO Trans. 1987 Apr-Jun;33(2):57-65. doi: 10.1097/00002480-198704000-00003.
Since 1981, the National CAPD Registry, sponsored by the National Institute of Arthritis, Diabetes, Digestive, and Kidney Diseases of the National Institutes of Health, has been systematically collecting demographic and follow-up data on patients receiving continuous ambulatory peritoneal dialysis (CAPD) as maintenance therapy for end-stage renal disease. Using life-table methods, this study has identified the association of diabetic glomerulosclerosis with age over 60 or under 20 years as factors jointly relevant in predicting peritonitis, hospitalization, or death. In addition, these outcomes were more likely to occur if patients were black and had been exposed to other dialytic therapy earlier on. The latter two were the only factors jointly predictive of transfer from CAPD onto hemodialysis. Careful monitoring of patients with the above mentioned characteristics may reduce complications, and lead to greater success with this increasingly popular dialysis modality.
自1981年以来，由美国国立卫生研究院下属的国立关节炎、糖尿病、消化和肾脏疾病研究所赞助的国家持续性非卧床腹膜透析登记处，一直在系统收集接受持续性非卧床腹膜透析（CAPD）作为终末期肾病维持治疗患者的人口统计学和随访数据。本研究采用寿命表法，确定了糖尿病肾小球硬化与60岁以上或20岁以下年龄作为共同预测腹膜炎、住院或死亡的相关因素。此外，如果患者为黑人且早期接受过其他透析治疗，则这些结局更有可能发生。后两个因素是唯一共同预测从CAPD转为血液透析的因素。对具有上述特征的患者进行仔细监测可能会减少并发症，并使这种越来越受欢迎的透析方式取得更大成功。
